Javascript must be enabled to continue!
Alternative therapies, 1990: An overview
View through CrossRef
AbstractThe availability of alternative therapies for many health problems is a well‐documented historical fact. Alternative therapies are generally understood to be those therapies outside of the usually accepted medical therapies for disease processes, such as cancer, arthritis, diabetes, psoriasis, lupus, and AIDS. Some other descriptive terms utilized include questionable, unproven, dubious, unorthodox, and unconventional. These alternative therapies vary from active involvement in promotion of one's own health (exercise, diet) to quackery. In today's society, with emphasis on self‐involvement with individual health, metabolic therapies have become the most widely practiced alternative therapy. In an antiestablishment, anti‐intellectual climate, with an increasingly mobile, rootless population, alternative therapies are in somewhat of a renaissance. Some confusion exists regarding clinical trials and alternative therapies in the general population and in the noninvolved health profession. Various studies indicate that from 10% to 50% of cancer patients use some alternative therapy, with national expenditures ranging as high as $10 billion annually. Better‐educated patients with higher‐than‐average income are more likely to choose alternative therapies and are frequently supported by a physician in this choice. Most cancer patients continue under a physician's care and continue usual therapy while pursuing alternative methods. Approximately 5% of cancer patients abandon appropriate therapy and pursue potentially harmful alternative methods. A variety of sociomedical questions are brought forth by studies of the use of alternative therapies. A great need for public and professional education regarding this subject is evident.
Title: Alternative therapies, 1990: An overview
Description:
AbstractThe availability of alternative therapies for many health problems is a well‐documented historical fact.
Alternative therapies are generally understood to be those therapies outside of the usually accepted medical therapies for disease processes, such as cancer, arthritis, diabetes, psoriasis, lupus, and AIDS.
Some other descriptive terms utilized include questionable, unproven, dubious, unorthodox, and unconventional.
These alternative therapies vary from active involvement in promotion of one's own health (exercise, diet) to quackery.
In today's society, with emphasis on self‐involvement with individual health, metabolic therapies have become the most widely practiced alternative therapy.
In an antiestablishment, anti‐intellectual climate, with an increasingly mobile, rootless population, alternative therapies are in somewhat of a renaissance.
Some confusion exists regarding clinical trials and alternative therapies in the general population and in the noninvolved health profession.
Various studies indicate that from 10% to 50% of cancer patients use some alternative therapy, with national expenditures ranging as high as $10 billion annually.
Better‐educated patients with higher‐than‐average income are more likely to choose alternative therapies and are frequently supported by a physician in this choice.
Most cancer patients continue under a physician's care and continue usual therapy while pursuing alternative methods.
Approximately 5% of cancer patients abandon appropriate therapy and pursue potentially harmful alternative methods.
A variety of sociomedical questions are brought forth by studies of the use of alternative therapies.
A great need for public and professional education regarding this subject is evident.
Related Results
The current socioeconomic and regulatory landscape of immune effector cell therapies
The current socioeconomic and regulatory landscape of immune effector cell therapies
Immune cell effector therapies, including chimeric antigen receptor (CAR)-T cells, T-cell receptor (TCR) T cells, natural killer (NK) cells, and macrophage-based therapies, represe...
Use of Alternative Medications in Patients with Neurologic Disorders
Use of Alternative Medications in Patients with Neurologic Disorders
OBJECTIVE: To determine alternative medication use in a neurology clinic population and to predict patients likely to use alternative medications. DESIGN: Survey of 216 adults pres...
Gene and Cell Therapies Overview Under the Light of Health Economics
Gene and Cell Therapies Overview Under the Light of Health Economics
With the increase in drug development studies for rare diseases, gene therapies have recently come to the fore more frequently. In addition to orphan drugs used in the treatment of...
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
AbstractIntroductionEmergence of new therapies are anticipated to improve clinical outcomes and quality of life of persons with haemophilia. Challenges in conducting randomized cli...
Current therapeutic trends for tinnitus cure and control – a scoping review
Current therapeutic trends for tinnitus cure and control – a scoping review
AbstractIntroductionChronic tinnitus treatment has been an enigma due to a lack of practice insights. To date, there has been limited evidence-based research on tinnitus therapies ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic review
Is complementary and alternative medicine (CAM) cost-effective? a systematic review
Abstract
Background
Out-of-pocket expenditures of over $34 billion per year in the US are an apparent testament to a widely held bel...
Abstract 1791: An injectable depot technology for sustained locoregional delivery improves the efficacy and safety of immunotherapies and adoptive cell therapies
Abstract 1791: An injectable depot technology for sustained locoregional delivery improves the efficacy and safety of immunotherapies and adoptive cell therapies
Abstract
Advances in immunotherapy have revolutionized care for cancer patients. Unfortunately, many approaches fail to mount a robust anti-cancer effect, in part du...
De door de Regering gegeven garantie, ex artikel 15 lid 2 Petroleumwet 1990, in het licht van de petroleumovereenkomsten, gesloten tussen Staatsolie en Contractors, nader bekeken
De door de Regering gegeven garantie, ex artikel 15 lid 2 Petroleumwet 1990, in het licht van de petroleumovereenkomsten, gesloten tussen Staatsolie en Contractors, nader bekeken
De door de Regering gegeven garantie, ex artikel 15 lid 2 Petroleumwet 1990, in het licht van de petroleumovereenkomsten, gesloten tussen Staatsolie en Contractors, nader bekeken
...

